Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OMthis companyOutset Medical, Inc.	$4.37	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
CATXPerspective Therapeutics, Inc.	$0.82	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
HSDTSolana Company	$1.89	-1.56×	0.21×	10.59×	-1.43×	-610.6%	91.7%	-351.0%	-679.6%	-13.6%	-7.0%	-96.2%	0×	0.18×	-33.26×	10.33×	0.0%	3	1.76	1	C-
INGNInogen, Inc.	$5.92	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
QTRXQuanterix Corporation	$3.25	-2.53×	0.92×	1.96×	-2.98×	-844.7%	46.7%	-79.2%	-77.3%	-36.2%	-29.8%	-29.4%	0.13×	-0.08×	0×	2.84×	0.0%	2	-2.21	3	B
SIShoulder Innovations, Inc.	$19.77	-7.3×	2.1×	6.23×	-7.64×	-723.5%	76.5%	-55.6%	-85.3%	-28.7%	-16.9%	-12.2%	0.11×	0.32×	-375.67×	11.07×	0.0%	2	8.22	1	C-
Peer median	—	-2.53×	0.95×	1.96×	-2.98×	-610.6%	47.6%	-55.6%	-77.3%	-28.7%	-16.9%	-29.4%	0.09×	0.27×	-33.26×	5.17×	0.0%	3	1.53	2	—